首页 | 本学科首页   官方微博 | 高级检索  
     


Pathologic hepatic Tc-99m-MDP uptake in polyostotic fibrous dysplasia
Authors:Ersrsoy?Kekilli  author-information"  >  author-information__contact u-icon-before"  >  mailto:ekekilli@inonu.edu.tr"   title="  ekekilli@inonu.edu.tr"   itemprop="  email"   data-track="  click"   data-track-action="  Email author"   data-track-label="  "  >Email author,Cengiz?Yagmur,Akin?Kuzucu,Omer?Soysal,Ayse?Sertkaya?Cikim,Kadir?Ertem
Affiliation:Department of Nuclear Medicine, Inonu University, Turgut Ozal Medical Center, Malatya, Turkey. ekekilli@inonu.edu.tr
Abstract:Fibrous dysplasia of bone is a congenital, sporadic developmental disorder characterized by immature fibrous connective tissue and bone deformities. Hepatic Tc-99m-MDP uptake is a rare, serendipitous finding during bone scanning studies. The present patient was a 25-year-old male who had severe polyostotic fibrous dysplasia. On Tc-99m-MDP (methylene diphosphonate) bone scintigraphy, increased activity accumulations were seen on multiple ribs, vertebrae and base of the cranium. In addition, diffuse increased pathologic uptake of Tc-99m-MDP in the liver was shown. Intravenous pamidronate was administered monthly for two months. In the third week of the last administration Tc-99m-MDP bone scintigraphy was performed again, but despite sustained bone involvement, pathologic hepatic uptake was not seen on the scan. We thought that pathologic hepatic Tc-99m-MDP accumulation, may be related to the formation and aggregation of calcium oxalate and phosphate crystals which improved with pamidromat treatment.
Keywords:fibrous dysplasia  hepatic  extra-osseous
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号